UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Radiation enteropathy--pathogenesis, treatment and prevention

Nature reviews. Gastroenterology & hepatology, 2014-08, Vol.11 (8), p.470

2014

Volltextzugriff (PDF)

An Atlas-Based Electron Density Mapping Method for Magnetic Resonance Imaging (MRI)-Alone Treatment Planning and Adaptive MRI-Based Prostate Radiation Therapy

International journal of radiation oncology, biology, physics, 2012-05, Vol.83 (1), p.e5-e11

2012

Volltextzugriff (PDF)

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

The lancet oncology, 2011-05, Vol.12 (5), p.451-459

2011

Volltextzugriff (PDF)

Tumor innervation and clinical outcome in pancreatic cancer

Scientific reports, 2021-04, Vol.11 (1), p.7390-7390, Article 7390

2021

Volltextzugriff (PDF)

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2420-2425

2007

Volltextzugriff (PDF)

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

Histopathology, 2020-08, Vol.77 (2), p.284-292

2020

Volltextzugriff (PDF)

MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning

Radiotherapy and oncology, 2011-03, Vol.98 (3), p.330-334

2011

Volltextzugriff (PDF)

Defining pelvic-radiation disease for the survivorship era

The lancet oncology, 2010-04, Vol.11 (4), p.310-312

2010

Volltextzugriff (PDF)

The radiotherapeutic injury – a complex ‘wound’

Radiotherapy and Oncology, 2002-05, Vol.63 (2), p.129-145

2002

Volltextzugriff (PDF)

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

The lancet oncology, 2012-02, Vol.13 (2), p.189-195

2012

Volltextzugriff (PDF)

Gastrointestinal Dose-Histogram Effects in the Context of Dose-Volume–Constrained Prostate Radiation Therapy: Analysis of Data From the RADAR Prostate Radiation Therapy Trial

International journal of radiation oncology, biology, physics, 2015-03, Vol.91 (3), p.595-603

2015

Volltextzugriff (PDF)

Treatment-Related Morbidity in Prostate Cancer: A Comparison of 3-Dimensional Conformal Radiation Therapy With and Without Image Guidance Using Implanted Fiducial Markers

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (4), p.1018-1023

2013

Volltextzugriff (PDF)

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

The lancet oncology, 2012-12, Vol.13 (12), p.1260-1270

2012

Volltextzugriff (PDF)

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

Frontiers in oncology, 2020-07, Vol.10, p.1174

2020

Volltextzugriff (PDF)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost

Frontiers in oncology, 2020-06, Vol.10, p.910-910

2020

Volltextzugriff (PDF)

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats

PloS one, 2014-02, Vol.9 (2), p.e89087

2014

Volltextzugriff (PDF)

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

The lancet oncology, 2008-11, Vol.9 (11), p.1058-1068

2008

Volltextzugriff (PDF)

Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced Prostate Cancer Treated With Radiotherapy

Seminars in radiation oncology, 2013-07, Vol.23 (3), p.206-214

2013

Volltextzugriff (PDF)

Histopathology and oxidative stress analysis of concomitant misoprostol and celecoxib administration

Journal of Toxicologic Pathology, 2015, Vol.28(3), pp.165-170

2015

Volltextzugriff (PDF)

A Comparison of the Prognostic Value of Early PSA Test-Based Variables Following External Beam Radiotherapy, With or Without Preceding Androgen Deprivation: Analysis of Data From the TROG 96.01 Randomized Trial

International journal of radiation oncology, biology, physics, 2011-02, Vol.79 (2), p.385-391

2011

Volltextzugriff (PDF)

Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial

Journal of medical imaging and radiation oncology, 2013-04, Vol.57 (2), p.247-257

2013

Volltextzugriff (PDF)

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4682-4687

2011

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(202)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(156)
Humans
(134)
Male
(109)
Oncology
(87)
Radiology, Nuclear Medicine & Medical Imaging
(62)
Aged
(55)
Middle Aged
(52)
Prostatic Neoplasms - Radiotherapy
(51)
Prostate Cancer
(43)
Female
(36)
Biological And Medical Sciences
(33)
Radiotherapy
(31)
Hematology, Oncology And Palliative Medicine
(29)
Medical Sciences
(29)
Radiotherapy Dosage
(27)
Prostatic Neoplasms - Drug Therapy
(26)
Androgen Antagonists - Therapeutic Use
(25)
Treatment Outcome
(25)
Radiation Therapy
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Radiation enteropathy--pathogenesis, treatment and prevention

An Atlas-Based Electron Density Mapping Method for Magnetic Resonance Imaging (MRI)-Alone Treatment Planning and Adaptive MRI-Based Prostate Radiation Therapy

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

Tumor innervation and clinical outcome in pancreatic cancer

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning

Defining pelvic-radiation disease for the survivorship era

The radiotherapeutic injury – a complex ‘wound’

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

Gastrointestinal Dose-Histogram Effects in the Context of Dose-Volume–Constrained Prostate Radiation Therapy: Analysis of Data From the RADAR Prostate Radiation Therapy Trial

Treatment-Related Morbidity in Prostate Cancer: A Comparison of 3-Dimensional Conformal Radiation Therapy With and Without Image Guidance Using Implanted Fiducial Markers

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced Prostate Cancer Treated With Radiotherapy

Histopathology and oxidative stress analysis of concomitant misoprostol and celecoxib administration

A Comparison of the Prognostic Value of Early PSA Test-Based Variables Following External Beam Radiotherapy, With or Without Preceding Androgen Deprivation: Analysis of Data From the TROG 96.01 Randomized Trial

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer

Suchergebnisse filtern